Skip to main content
2026 CRT Conference Main banner

CRT 2026

Session:: CARDIOTUBE INTERVIEW

Cardiotube Interview: LBCT - Paclitaxel-coated Versus Uncoated Balloon For Coronary In-stent Restenosis - Three-year Outcomes Of The Agent IDETrial

Sunday, March 8, 2026
7:45 AM - 8:00 AM EST
Location: Lobby Level - Next to Speaker Ready

    Interviewer(s)

  • David J. Cohen, MD, FSCAI

    Director of Clinical and Outcomes Research
    Cardiovascular Research Foundation
    New York, New York, United States

    Disclosure(s): Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

    • Interviewee(s)

  • Robert W. Yeh, MD, MSc

    Professor of Medicine
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):
David J. Cohen, MD, FSCAI: Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
Robert W. Yeh, MD, MSc: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing)